- E23.3 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM E23.3 became effective on October 1, 2022.
- This is the American ICD-10-CM version of E23.3 – other international versions of ICD-10 E23.3 may differ.
ICD-10-CM E23.3 is grouped within Diagnostic Related Group(s):
- 643 Endocrine disorders with mcc
- 644 Endocrine disorders with cc
- 645 Endocrine disorders without cc/mcc
Type 1 Excludes
- Prader-Willi syndrome (Q87.11)
- Russell-Silver syndrome (Q87.19)
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to E23.3:
- neurohypophysis NEC > Disorder (of)
- hypothalamic NEC > Dysfunction
- pituitary (gland) > Dysfunction
- hypothalamus > Overactive